Inventor · disambiguated record
Charles Allerson
Also filed as: ALLERSON CHARLES · ALLERSON CHARLES R
23 granted patents·43 pending applications·2,222 citations·filing 2002–2025
97Inventor score
Files withBHAT BALKRISHEN17ISIS PHARMACEUTICALS INC13REGULUS THERAPEUTICS INC13ALLERSON CHARLES6IONIS PHARMACEUTICALS INC4
Top patents by PatentIndex Score
66 records- 0199US9005906B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·163 cites·24 claims
- 0299US8440803B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2011·Granted May 14, 2013·158 cites·16 claims
- 0399US7696345B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2003·Granted Apr 13, 2010·426 cites·24 claims
- 0498US8796437B2Tetrahydropyran nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2013·Granted Aug 5, 2014·85 cites·23 claims
- 0598US8124745B2Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulationALLERSON CHARLES·Filed 2010·Granted Feb 28, 2012·203 cites·20 claims
- 0698US8088904B2Tetrahydropyran nucleic acid analogsSWAYZE ERIC E·Filed 2008·Granted Jan 3, 2012·164 cites·30 claims
- 0798US7939677B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2010·Granted May 10, 2011·152 cites·20 claims
- 0898US7875733B2Oligomeric compounds comprising 4′-thionucleosides for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2004·Granted Jan 25, 2011·159 cites·6 claims
- 0998US7569686B1Compounds and methods for synthesis of bicyclic nucleic acid analogsISIS PHARMACEUTICALS INC·Filed 2007·Granted Aug 4, 2009·501 cites·26 claims
- 1096US10266825B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2017·Granted Apr 23, 2019·10 cites·21 claims
- 1194US6610492B1Base-modified nucleotides and cleavage of polynucleotides incorporating themVARIAGENICS INC·Filed 2002·Granted Aug 26, 2003·108 cites·15 claims
- 1292US9708610B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2015·Granted Jul 18, 2017·6 cites·19 claims
- 1390US8604183B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2003·Granted Dec 10, 2013·20 cites·24 claims
- 1488US9193752B25′-substituted bicyclic nucleosides and oligomeric compounds prepared therefromMIGAWA MICHAEL T·Filed 2011·Granted Nov 24, 2015·14 cites·25 claims
- 1588US8779118B2Base modified bicyclic nucleosides and oligomeric compounds prepared therefromALLERSON CHARLES·Filed 2011·Granted Jul 15, 2014·14 cites·42 claims
- 1686US9150606B2Compositions comprising alternating 2'-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2005·Granted Oct 6, 2015·9 cites·21 claims
- 1785US8394947B2Positionally modified siRNA constructsBHAT BALKRISHEN·Filed 2004·Granted Mar 12, 2013·17 cites·15 claims
- 1883US2024141350A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1982US9150605B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationALLERSON CHARLES·Filed 2004·Granted Oct 6, 2015·9 cites·22 claims
- 2078US2023109466A1Compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2177US2022162603A1Compositions comprising alternating 2'-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2275US2022213483A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2374US11078485B2Compositions comprising alternating 2′-modified nucleosides for use in gene modulationIONIS PHARMACEUTICALS INC·Filed 2019·Granted Aug 3, 2021·0 cites·7 claims
- 2474US6994998B1Base-modified nucleotides and their use for polymorphism detectionSEQUENOM INC·Filed 2002·Granted Feb 7, 2006·3 cites·20 claims
- 2571US2025283082A1Compositions for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2670US2021095282A1Modified Oligonucleotides for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2769US2020392501A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2867US2007173474A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 2967US2007179109A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3067US2007179106A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3167US2007123484A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3267US2007167390A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3367US2007167392A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3467US2007185046A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3567US2022380767A1Methods and compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3667US2007167391A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3767US2007185047A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3867US2007179108A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 3966US2007179107A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4064US12497616B2Compounds targeting PMP22 for the treatment of Charcot-Marie-Tooth diseaseNOVARTIS AG·Filed 2024·Granted Dec 16, 2025·0 cites·28 claims
- 4164US12005120B2Galnac conjugated modified oligonucleotides as miR-122 inhibitor having HCV antiviral activity with reduced hyperbilirubinemia side-effectREGULUS THERAPEUTICS INC·Filed 2019·Granted Jun 11, 2024·0 cites·22 claims
- 4264US6855500B2Fluorescence-based genotypingSEQUENOM INC·Filed 2002·Granted Feb 15, 2005·1 cites·26 claims
- 4364US2020165606A1Modified Oligonucleotides for Treatment of Polycystic Kidney DiseaseREGULUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 4464US2007172948A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4564US2007173475A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4664US2007166734A1Double strand compositions comprising differentially modified strands for use in gene modulationBHAT BALKRISHEN·Filed 2006·Application pending·0 cites
- 4763US2025333745A1Methods and compositions for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4863US2016017328A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4963US2019345494A1Methods for treatment of polycystic kidney diseaseREGULUS THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 5062US2011046206A1Double strand compositions comprising differentially modified strands for use in gene modulationISIS PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Charles Allerson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →